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Combining physical training with transcranial direct current stimulation to improve gait in 
Parkinson’s disease: a pilot randomised controlled study 
Introduction 
Parkinson’s disease is a common cause of gait and postural instability, which may not respond to 
levodopa (1). Its treatment is therefore therapeutically challenging. Given the reduced activity in 
premotor and primary motor cortical regions in Parkinson’s disease (2), these areas may be important 
therapeutic non-invasive neurostimulatory targets for patients with Parkinson’s disease and gait 
disturbance (3).  
Physical training appears to induce physiological changes in the primary motor cortex of patients with 
Parkinson’s disease (4). Non-invasive brain stimulation techniques such as transcranial direct current 
stimulation (tDCS) has also been shown to improve motor learning and rehabilitation in Parkinson’s 
disease (5), and other primary gait disorders (6), although outcomes have been mixed (7).  
The objective of this study was to improve gait velocity (primary gait outcome) and the response on 
the pull test (primary balance outcome) in patients with Parkinson’s disease by combining tDCS with 
physical training. We hypothesised that anodal tDCS time-locked to physical training would improve 
gait and balance in Parkinson’s disease above and beyond the effects of tDCS in isolation. Our 
primary gait outcome was gait velocity as this is a functional marker of disease severity, and our 
primary balance outcome was recovery of stance in the pull test (8), postural instability being a 
common cause of falls in these patients.  
METHODS 
Trial design 
Patients were assigned to one of two groups (Figure 1: ‘physical-training’ [n=8] or ‘No physical-
training’ [n=8]) using an online randomisation software tool (Research Randomizer, Version 3.0). 
Patients in Group I received tDCS during a fifteen-minute period of physical training, as part of a 
nested study. Patients in Group II received only tDCS, without physical training. For both groups, the 
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application of tDCS was also randomised to either real tDCS stimulation or sham stimulation in the 
first session. All subjects returned 1 week later, to allow an appropriate wash-out period for the 
neurostimulation. In this second session subjects in the ‘physical training’ group again received 
physical training, but those that received real stimulation in the first session were given sham 
stimulation, and vice versa (Figure 1). Patients in the ‘No physical training’ group again received only 
neurostimulation in this second session, with those that received real stimulation in the first session 
given sham stimulation, and vice versa. Outcomes were recorded prior to any intervention (baseline), 
and after intervention (final assessment). Patients were assigned to three clinicians experienced in the 
application of both physical therapy and neurostimulation.  
Participants 
Forty consecutive patients fulfilling the UK Society Brain Bank criteria for idiopathic Parkinson 
disease (9) were approached for this study, within the allocated recruitment period of 1 year (Figure 
1). Written informed consent was obtained for all participants. Patients with severe freezing, daily 
falls, dementia (mini-mental state examination score (10) less than 24/30), or other disorders affecting 
gait and balance were excluded (n=14). All patients underwent magnetic resonance imaging of the 
brain to exclude alternative central nervous system pathologies that could affect gait. Each subject 
was tested whilst on medication, and assessments carried out at the same time of the day in the first 
and second session to avoid diurnal variation and on/off medication effects. 
The study was approved by the local ethics committee, and conducted in accordance to the 
Declaration of Helsinki. 
Interventions 
Physical training 
Our physical training protocol (Appendix 1) lasted 15 minutes and focused on improving gait 
initiation, stride length, gait velocity, arm swing, and balance. To stand from sitting, patients were 
instructed to shift their body forwards towards the edge of the seat, place the heels firmly on the 
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ground, as far back underneath the chair as possible, and move the centre of gravity forwards, to stand 
in a arc-like fashion forwards and upwards. They were instructed to walk taking long strides with 
adequate floor clearance, and swing the arms to maintain balance. For the turning practice, they were 
asked to use whole body movements, taking steps around objects to avoid rapidly switching direction. 
For balance practice patients were asked to pick a book from the floor using both hands, at increasing 
distance, by taking a forward step. They were also given backward pulls and instructed to take 
anticipatory steps to maintain balance when the pressure on the shoulders was felt. The protocol was 
designed by our local physiotherapists based on published practice recommendations (11).  
Transcranial direct current stimulation (tDCS) 
For the tDCS, we used an identical montage and stimulation protocol as described in Kaski et al., 
(12). Briefly, a direct current rectangular stimulating (anodal) electrode (10x4cm) was placed 
centrally across the scalp to cover a region 10-20% anterior to Cz as measured from the midline of the 
electrode. A reference electrode (4x4cm) was placed at the inion. A 2mA current was delivered for 15 
minutes during training (‘physical training’ group), or during the execution of the git and balance 
tasks (‘No physical training’ group). Electrodes were secured onto the scalp during the assessments 
using a modified diving head cap, and tDCS battery fitted on a lightweight backpack. 
Outcome measures 
The primary outcome for gait was gait velocity. Secondary outcomes included stride length, 3m 
‘Timed Up and Go’, 6m walk. The primary balance outcome was a quantitative pull test. All tests 
were recorded on video camera (Veho Kuzo HD camcorder) to assess gait velocity, stride length, and 
stride length variability. Observational assessments of gait have been previously validated in the 
clinical setting (13). 
For gait assessments, subjects were instructed to “walk as quickly, but safely, as possible”. The 
duration of walking during the middle 4m of the 6m walk was used to calculate mean gait velocity 
(m/s), to avoid variability from acceleration/deceleration effects. Stride length (distance from the 
initial contact of one foot with the ground to the following contact of the same foot) was measured 
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against floor markers 15cm apart, using frame-by-frame video analysis. Mean gait velocity for the 6m 
walk obtained from the Swaystar (see below) was cross-referenced with the video data acquisition for 
validation. 
For the Timed ‘Up and Go’, subjects began seated in an armless office chair and were asked to get up, 
walk 3 metres, turn round, return to the chair and sit down again. A verbal “go” signal was given to 
start the test. Subjects were asked to perform the task at a brisk but safe pace. The total duration of the 
task was calculated from the moment the subject began to get up until they were comfortable on the 
chair again. The ‘turn’ phase of the Timed ‘Up and Go’ was also analysed separately, using the 
Swaystar system. The onset of the turn was marked by a change in the polarity of the Swaystar 
angular displacement signal. The end of the turn was taken as the end of this polarity change, as the 
signal reached a plateau, before gait recommenced. 
The pull test is a clinical tool used to evaluate postural instability in patients with Parkinson’s disease 
(14). Subjects stood in a comfortable stance position with feet at shoulder width, and eyes open. They 
were warned that they would receive a sudden and firm shoulder pull, delivered by the examiner 
standing directly behind the subject. The examiner then delivered a single pull using sufficient 
strength in order to force subjects to take at least one corrective step backwards. The test was repeated 
a total of 3 times. The same examiner (DK) performed the pull test on every subject to reduce the pull 
strength variability. The shoulder pull forces were not quantitatively controlled but recordings showed 
that subjects’ backward trunk velocity was approximately equal (mean backward velocity = 
32.5deg/s, SD =5.8). Trunk sway recordings were started just prior to the pull and terminated 5 
seconds later, or until loss of balance occurred. Subjects were prevented from falling by the examiner 
and an assistant standing next to the subject. Angular trunk displacement and velocity was recorded 
for subjects in the pitch (sagittal) plane (SwayStar System, Balance Int. Innovations GmbH, 
Switzerland (15)) to provide a quantitative measure of the pull test in all subjects. Thus, for the 
recorded (angular trunk movements) version of the pull test we report the time taken to regain a trunk 
angular position within 2 degrees of the baseline (quiet standing), which is easy to measure 
objectively (Figure 2A) and correlates well with the number of falls in the preceding year (r=0.8, 
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p=0.0002; Figure 2B), suggesting it is a clinically relevant measure of imbalance. We also recorded 
the peak pull velocity and displacement (to ascertain stimulus consistency) and peak recovery phase 
velocity within the first second following maximum pitch backward displacement. 
Randomisation and blinding 
Randomisation was performed by the unblinded researcher by entering the anonymised patient details 
into the software prior to the patient’s arrival. This generated a code relating to the intervention arm 
(physical training versus no training), and stimulation type (real versus sham). Data were analysed 
blindly, without knowledge of whether patients received real or sham stimulation. 
Data analysis 
Video and SwayStar data were acquired simultaneously for all tasks. For the video data, the first three 
and the last two steps of each gait cycle were eliminated from the data set to remove acceleration and 
deceleration effects. Stride length was defined as the distance from the initial contact of one foot with 
the ground to the following contact of the same foot.  
Statistical methods 
Statistical analysis was carried out using SPSS 18.0 with significance set at p <0.05 (two-tailed), and 
consisted of paired student t-tests. Where Bonferroni correction was applied for multiple comparisons, 
the adjusted significance level is reported in the text. 
For individual correlations, correlation coefficients were compared using Fisher’s r-to-z 
transformation. z values were obtained using the formula zr = (1/2)[log e (1+r) – log e (1-r)] where r is 
the regression coefficient. A line was fitted through the data set using the method of least squares, and 
a z-test performed to calculate the p value.  
To assess the effect of combining tDCS with physical training we compared the average % change in 
performance in patients receiving real stimulation in Group I vs real stimulation in Group II. We 
compared the average % change in performance in patients receiving real vs sham stimulation in 
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Group II to assess the isolated effect of tDCS stimulation (independent of physical training). To assess 
the isolated effect of physical training (independent of tDCS) we compared the average % change in 
performance in patients receiving sham in Group I vs patients receiving sham stimulation in Group II. 
Where an isolated effect of physical training was observed, we compared the average % change in 
performance in patients receiving real stimulation in Group I vs sham stimulation in Group I, to assess 
the effect of combining tDCS with physical training - above and beyond the effect of physical training 
alone. 
Results 
Ten patients declined participation, and sixteen patients were enrolled.  
Table 1 shows the averaged percentage change for all groups and tasks, whilst absolute values for 
baseline and final assessments for all tasks are shown in Table 2. Statistical results are reported in the 
text. 
Gait velocity 
The combination of tDCS+physical training significantly increased gait velocity compared to tDCS 
alone (p<0.001). There was an isolated effect of physical training (p=0.03) but no overall effect of 
tDCS alone (p=0.12). Percentage increase in gait velocity was greater for patients receiving a 
combination of tDCS+physical training than with physical training alone. In the tDCS+physical 
training group, gait velocity correlated with UPDRS (r=0.77, p=0.025) but not with age, leukoaraiosis 
(Fazekas score) or mini-mental state examination (p>0.1 for all).  
Stride length 
Stride length increased between baseline and final assessments with combined tDCS+physical 
training, compared to tDCS alone (p=0.01). There was no isolated effect of stimulation (p=0.33), but 
physical training alone significantly increased stride length (p=0.03). The effects of tDCS+physical 
training were nevertheless greater than physical training alone (p=0.03). 
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Timed Up and Go 
There was no difference in baseline timed ‘Up and Go’ duration between real and sham stimulation 
groups (paired t-test; p=0.72 for the ‘physical training’ group, and p=0.85 for ‘No-physical training’ 
group). tDCS+physical training resulted in significant improvements for timed ‘Up and Go’ duration 
compared to tDCS alone (P=0.04). There was no isolated effect of tDCS (p=0.52) nor physical 
training (p=0.31). Sub-analysis of the turn phase of the timed ‘Up and Go’ also revealed significant 
improvements with tDCS+physical training, but not with tDCS or physical training alone.  
6 metre walk 
tDCS+physical training decrease walking time compared to tDCS alone (p=0.01) but tDCS had no 
effect in isolation (p=0.48). There was a significant effect physical training alone (p=0.042), but this 
was comparatively less than with tDCS+physical training (p=0.05). 
Pull test  
tDCS+physical training reduced the time taken to regain stability following the retropulsion stimulus 
(Figure 2A)  compared to tDCS alone (p=0.01). There was no isolated effect of stimulation (p=0.94) 
or physical training (p=0.87). 
Individual correlations 
In the tDCS+physical training group there was a positive correlation between disease severity 
and % reduction in walking time (timed ‘Up and Go’ vs. United Parkinson’s Disease Rating 
Scale; r=0.74, p=0.03; timed ‘Up and Go’ vs. Hoehn-Yahr stage; r=0.62, p=0.05) but not 
with age (United Parkinson’s Disease Rating Scale vs. age r=0.26, p=0.53), white matter 
disease (United Parkinson’s Disease Rating Scale vs. Fazekas r=0.005, p=0.99), or cognitive 
impairment (United Parkinson’s Disease Rating Scale vs. Mini-mental State Examination 
r=0.24, p=0.57). We performed post hoc analyses on ‘responders’ in the tDCS+Physical 
training group that had a moderate effect size (Cohen’s δ >0.5) in the timed ‘Up and Go’ and 
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6m walk (n=6). Improvements in gait were strongly correlated with the intensity of the 
dopaminergic treatment (timed ‘Up and Go’ vs. levodopa daily equivalent dose r=0.83, 
p=0.02; 6m walk vs. levodopa daily equivalent dose r=0.82, p=0.02). Additionally, there was 
a significant correlation between non-motor symptoms and improvements in gait (timed ‘Up 
and Go’ vs. United Parkinson’s Disease Rating Scale I: r=0.71, p=0.05; 6m walk vs. United 
Parkinson’s Disease Rating Scale I r=0.85, p=0.01).    
Discussion 
This double-blind, randomised, sham-controlled pilot study evaluated bihemispheric anodal tDCS 
with physical training as a ‘proof-of-principle’ treatment for gait and balance disturbance in 
Parkinson’s disease.  We found a significant benefit of combining tDCS with physical training for gait 
velocity (primary gait outcome) and the performance on the pull test (primary balance outcome), but 
no isolated effect of tDCS or physical training.  
Gait and balance impairment in patients with Parkinson’s disease have proved notoriously difficult to 
treat, and although some evidence suggests that freezing of gait may improve with levodopa (16), one 
study indicated that gait may worsen in medicated patients, perhaps as a result of drug-induced 
dyskinesia (17). As a result, there has been a drive towards non-pharmacological therapies. Deep 
brain stimulation has revolutionised the management of dopaminergic motor features in many patients 
with severe Parkinson’s disease, and whilst there is some evidence in support for in the treatment of 
gait disorders in these patients (18), it’s effect on the non-dopaminergic motor features of Parkinson’s 
disease, such as gait and balance has been disappointing. Non-invasive treatment options, in particular 
repetitive transcranial magnetic stimulation showed early promise in the treatment of gait in this 
group of patients (19, 20), but subsequent studies using intermittent magnetic stimulation (21) and 
tDCS (22) have yielded negative results. One study assessed the effect of tDCS when applied 
concomitantly with gait rehabilitation in patients with chronic stroke finding no additional benefit 
over and above rehabilitation alone (23). In contrast, tDCS applied during physical gait and balance 
training improved gait velocity and balance in patients with small vessel disease (6).    
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Combining physical gait and balance training with tDCS over primary motor and premotor cortex has 
a physiological basis - physical training in Parkinson’s disease normalises cortical excitability in M1 
(4), whilst tDCS may lower the threshold for these changes to occur. Given the bilateral 
representation of cortical gait regions, one might expect improvements in gait to require simultaneous 
modulation of cortical activity bilaterally. Cortical leg stimulation using non-invasive techniques is 
more challenging than upper limb cortical stimulation given its deeper anatomical location, and more 
vertical orientation than the hand motor cortex. The electrode montage used in the present study was 
previously shown to alter cortical excitability in both lower limbs (12), but not hand areas, with a 
sufficiently high current to penetrate deep into the medial surface of the cortex (24), rather than the 
cortical convexity (12). Our anodal electrode covered a surface overlying primary motor and premotor 
areas but we cannot comment on possible differential stimulatory effects over these respective cortical 
regions. 
Patients with more severe motor symptoms (United Parkinson’s Disease Rating Scale III and 
Hoehn Yahr scale) tended to show an improvement in walking time (primary outcome) with tDCS 
compared to patients with milder disease. Although the number of patients tested is insufficient to 
draw firm conclusions from a correlation analysis, our data suggest that patients with more advanced 
disease are more likely to benefit from combined direct current stimulation and physical training than 
patients with mild disease. In contrast, individual gait outcomes did not correlate with age, the degree 
of leukoaraiosis, or cognitive impairment, suggesting that individual patients at the extremes of the 
disease process may be less likely to respond to neurostimulation. We cannot comment on whether 
disease severity or dopaminergic treatment dose was responsible for the improvements in gait 
apparent in this small number of individual patients. Our results suggest that further therapeutic 
studies combining direct current stimulation and dopaminergic medications are warranted.  
There are a number of limitations of this study. Firstly, whilst our patient sample size is 
adequate for a pilot proof-of-principle study, it lacks the power to draw conclusive results 
regarding the combination of physical training and tDCS to improve gait in patients with 
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Parkinson’s disease. Based on the observed effect size in this pilot study, a power calculation 
revealed that at least 14 patients per treatment arm (α = 0.05; power = 0.8) should be 
recruited for a definitive trial.  Secondly, the lack of follow-up assessments meant that we 
were unable to comment on possible longer-term benefit of the interventions. Finally, we 
recognise that there may have been the potential for selection bias given that we sought to 
include only patients with Parkinson’s disease with a primary complaint of a gait disorder. 
This was however a necessary selection process to explore the effect of tDCS and physical 
training on gait. 
In conclusion, we have shown that the combination of anodal tDCS placed centrally over the 
primary motor and premotor cortices of both hemispheres improves gait velocity and balance 
in patients with Parkinson’s disease. Our results suggest that clinical rehabilitation of gait in 
these patients could be combined with tDCS to enhance the effects of therapy.   
Clinical Messages 
Combining non-invasive brain stimulation to the motor cortex during physical training may 
improve gait and balance in patients with Parkinson’s disease.  
Power calculations revealed that 14 patients per treatment arm (α=0.05; power=0.8) are required for a 
definitive trial. 
Better outcomes were observed in patients with more advanced disease. 
Our results suggest that clinical rehabilitation of gait in these patients could be combined with 
tDCS to enhance the effects of therapy. 
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Figure legends 
 
Figure 1. Flow diagram showing enrolment and outcomes.  
Figure 2. The pull test: representative traces and objective outcome measures, and correlation between 
pull test data and number of falls in the previous year.  
(A) Representative traces for a patient (black line) and healthy age-matched control (grey line) for the pull test. 
Time taken to regain posture (duration to recovery) was calculated in seconds from the onset of the first 
negative displacement of the trunk pitch trace (small arrowhead) to arriving at +/- 2SD of the baseline pitch 
trace (large arrowhead). The peak recovery velocity (Vp) within the first 100ms after peak backward 
displacement was calculated from the differential of the position trace (inset). The main outcome measure was 
time (s) taken to regain posture following the retropulsive stimulus. Vertical bars represent standard errors. (B) 
Correlation between number of falls in the preceding year and the time (s) taken to regain posture following the 
retropulsive stimulus (objective measure for the pull test). Number of falls in the preceding year were calculated 
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using patient’s medical records, and questionnaire data. Data from the pull test are from the current study. * 
p<0.05 
Table 1. Comparison of different gait and balance measures between patients undergoing physical 
training and without physical training. 
Table 2. Grouped data showing absolute values for gait velocity, stride length, Timed Up and Go 
duration, 6m walk duration and pull test results.  
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Table 1. Comparison of the different gait and balance measures between patients 
undergoing physical training and without physical training 
 
Group 
Measure 
Group I ( n = 8) Group II ( n =  8 ) 
Stimulation % Change SD % Change SD 
Real (n = 8)           
 6m Walk (s) -18.89 15.1 -4.29 10.9 
 Gait velocity (m/s) -29.53 13.66 -7.65 15.5 
 Stride length (m) 54.21 17.16 13.02 11.2 
 TUG (s) -45.3 29.3 -10.89 8.8 
 Turn -66.7 12.8 -2.5 10.3 
 Retropulsion (s) -50.89 36.5 -1.44 31.5 
Sham (n = 8)           
 6m Walk (s) -7.8 16.2 -0.96 9.0 
 Gait velocity (m/s) -15.51 12.3 2.91 10.1 
 Stride length (m) 17.86 13.8 2.55 12.1 
 TUG (s) -18.41 9.24 -5.99 10.57 
 Turn -15.3 8.9 -4.5 10.6 
  Retropulsion (s) -1.44 11.5 -0.49 11.1 
 
 
Table 2. Grouped data showing absolute values for gait velocity, stride length, 
Timed Up and Go duration, 6m walk duration and pull test results. 
 
Group 
Measure 
Group I ( n = 8) Group II ( n =  8 ) 
Stimulation 
Baseline 
(SD) 
Final  
(SD) 
Baseline 
(SD) 
Final  
(SD) 
Real (n = 8)           
 6m Walk (s) 9.20 (3.7) 6.33 (2.8) 8.27 (1.5) 7.96 (1.3) 
 Gait velocity (m/s) 0.63 (0.15) 0.86 (0.25) 0.63 (0.11) 0.72 (0.12) 
 Stride length (m) 90.0 (18.9) 127.3 (17.7) 90.9 (16.1) 95.2 (16.1) 
 TUG (s) 11.43 (3.7) 9.50 (3.1) 11.24(3.3) 11.17 (2.6) 
 Turn 4.50 (3.7) 2.69 (2.1) 4.17 (1.0) 3.95 (1.4) 
 Retropulsion (s) 2.14 (1.5) 1.07 (0.51) 2.08 (0.9) 2.05 (0.9) 
Sham (n = 8)       
 6m Walk (s) 8.70 (3.5) 7.66 (2.8) 8.48 (1.1) 8.69 (1.3) 
 Gait velocity (m/s) 0.65 (0.14) 0.81 (0.14) 0.59 (0.15) 0.60 (0.12) 
 Stride length (m) 91.4 (21.7) 120.7 (22.6) 89.4 (17.6) 90.6 (16.1) 
 TUG (s) 11.02 (2.4) 9.37 (1.5) 11.24(3.3) 11.17 (2.6) 
 Turn 4.11(2.0) 3.57 (1.9) 4.14 (1.2) 4.00 (1.1) 
  Retropulsion (s) 2.07 (1.2) 1.51 (0.8) 2.01 (1.2) 2.00 (1.0) 
 
  
 15 
Appendix 1. Exercise protocol for the physical training group. 
 
Exercise Programme for PD 
Stand up from a sitting position 
Follow a sequence of four actions: 
• Shifting the body forward so that the buttocks are close to the edge of the 
chair, 
• Placing the feet flat on the floor so that the heels are well back, 
• Leaning the trunk forward, and 
• Standing up quickly while thinking of leaning “forward and up” in an arc of 
movement. 
Note: It is useful to start with a chair with a high seat and armrests so the sit-to-
stand action is performed independently and to gradually reduce seat height (and 
presence of armrests). 
Walking 
Walk with long strides and adequate ground clearance in different walking speed 
• Initially, draw some lines on the floor and ask the patient to walk by 
following the lines with large steps 
• Give the patient a rhythmical beat to generate a more normal stepping 
rate 
• Ask the patient to walk with swinging the arms to help balancing 
Walk with long strides and take a side step at the end 
Step over obstacles while walking 
Note: Remind the patient to stand upright and look forward while walking 
Turning 
Turn in a large arc of movement by using full body movements rather than focusing 
on rapidly switching directions 
• Put an object, such as a chair, in the centre of turning and ask the patient 
to turn by taking steps around the object 
In very small spaces, where turning in a large arc is not possible, the “clock turn” 
strategy is recommended 
Note: Attention is directed to lifting the feet clear in a deliberate stepping action, 
rather than shuffling or swivelling around 
Balance training 
Forward reach a target with both hands to different directions, from closer to 
further distance 
Pick up some objects from the floor (or a lower place) to a higher place 
